GlaxoSmithKline Consumer Healthcare Pakistan Limited reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was PKR 24,163.15 million compared to PKR 19,846.11 million a year ago. Net income was PKR 2,134.33 million compared to PKR 1,262.01 million a year ago.

Basic earnings per share from continuing operations was PKR 18.23 compared to PKR 10.78 a year ago.